CHRISTINA PASUKINIS: Open Payments
NPI 1588399232 · BLOOMSBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,186 in 62 payments from 20 companies in 2025. Trend: 2023 $1,326 · 2024 $1,143 · 2025 $1,186
Food & beverage: $1,186
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $348 |
| Novo Nordisk Inc | 8 | $160 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $78 |
| Phathom Pharmaceuticals, Inc. | 4 | $74 |
| GlaxoSmithKline, LLC. | 4 | $73 |
| AstraZeneca Pharmaceuticals LP | 4 | $69 |
| Esperion Therapeutics, Inc. | 2 | $44 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Merck Sharp & Dohme LLC | 2 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
Products named: VRAYLAR, QULIPTA, UBRELVY, Kerendia, Wegovy, VOQUEZNA, NEXLETOL, AREXVY.
Industry payments across PA — which companies pay providers there.
